ÂÜÀòÂÒÂ×

Dr. Matosevic is an assistant professor in the College of Pharmacy at Purdue University and is a member of the Purdue Center for Cancer Research. Dr. Matosevic runs an NIH-funded research program focused on the development and use of natural killer cells in the treatment of cancer and holds a number of patents on the engineering and utilization of NK cells in cancer immunotherapy.

Dr. Matosevic is on the editorial board of several journals and has been on committees and advisory boards of several organizations advancing the development and standardization of cell-based therapies, including the International Society for Cell & Gene Therapy. Prior to joining Purdue, Dr. Matosevic was senior Director of Research and Development at Akron Biotech. Dr. Matosevic obtained his graduate degree from University College London and completed his postdoctoral training at the Scripps Research Institute.